Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains.

PubWeight™: 2.23‹?› | Rank: Top 2%

🔗 View Article (PMC 263911)

Published in J Clin Microbiol on August 01, 1994

Authors

M Kristjánsson1, M H Samore, D N Gerding, P C DeGirolami, K M Bettin, A W Karchmer, R D Arbeit

Author Affiliations

1: Section of Infectious Diseases, Medical Service, VA Medical Center, Boston, Massachusetts 02130.

Articles citing this

Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79

Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol (2000) 2.41

Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism. J Clin Microbiol (2002) 2.21

Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis. Appl Environ Microbiol (1998) 2.02

Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85

Analysis of the unexplored features of rrs (16S rDNA) of the Genus Clostridium. BMC Genomics (2011) 1.60

Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev (2006) 1.57

Use of pulsed-field gel electrophoresis for epidemiological study of Escherichia coli O157:H7 during a food-borne outbreak. Appl Environ Microbiol (1995) 1.52

Prevalence of Clostridium botulinum in Finnish trout farms: pulsed-field gel electrophoresis typing reveals extensive genetic diversity among type E isolates. Appl Environ Microbiol (1998) 1.47

Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile. J Clin Microbiol (1996) 1.46

Subtyping of Haemophilus influenzae strains by pulsed-field gel electrophoresis. J Clin Microbiol (1999) 1.41

Efficient DNA fingerprinting of Clostridium botulinum types A, B, E, and F by amplified fragment length polymorphism analysis. Appl Environ Microbiol (2005) 1.32

Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C. J Clin Microbiol (1996) 1.31

Comparison of DNA fingerprinting methods for use in investigation of type E botulism outbreaks in the Canadian Arctic. J Clin Microbiol (2006) 1.28

Biodiversity of Clostridium botulinum type E strains isolated from fish and fishery products. Appl Environ Microbiol (1999) 1.24

PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J Clin Microbiol (1995) 1.21

Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates. J Clin Microbiol (1995) 1.18

Pulsed-field gel electrophoresis can yield DNA fingerprints of degradation-susceptible Clostridium difficile strains. J Clin Microbiol (2002) 1.06

Molecular subtyping of poultry-associated type A Clostridium perfringens isolates by repetitive-element PCR. J Clin Microbiol (2006) 1.00

Evaluation of repetitive element sequence-based PCR as a molecular typing method for Clostridium difficile. J Clin Microbiol (2003) 0.95

Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates. J Clin Microbiol (1996) 0.94

Identification of Clostridium species and DNA fingerprinting of Clostridium perfringens by amplified fragment length polymorphism analysis. J Clin Microbiol (2006) 0.92

Differentiation of Erwinia amylovora strains by pulsed-field gel electrophoresis. Appl Environ Microbiol (1997) 0.90

Prevalence and characterization of genotypic diversity of Haemophilus parasuis isolates from southern China. Can J Vet Res (2012) 0.87

Nosocomial outbreak of Clostridium difficile diarrhea in a pediatric service. Eur J Clin Microbiol Infect Dis (1997) 0.86

Molecular typing of Clostridium perfringens from a food-borne disease outbreak in a nursing home: ribotyping versus pulsed-field gel electrophoresis. J Clin Microbiol (2003) 0.84

Development of a PCR-restriction fragment length polymorphism assay for the epidemiological analysis of Shiga toxin-producing Escherichia coli. J Clin Microbiol (2004) 0.84

Comparison of restriction enzyme analysis, arbitrarily primed PCR, and protein profile analysis typing for epidemiologic investigation of an ongoing Clostridium difficile outbreak. J Clin Microbiol (1998) 0.79

Articles cited by this

A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis (1988) 10.73

Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33

Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72

Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis (1993) 7.60

Evoked potentials: computer-automated threshold-tracking procedure using an objective detection criterion. Ear Hear (1987) 5.89

DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol (1992) 5.35

Comparison of ribotyping and restriction enzyme analysis using pulsed-field gel electrophoresis for distinguishing Legionella pneumophila isolates obtained during a nosocomial outbreak. J Clin Microbiol (1992) 5.31

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis (1992) 3.37

Nosocomial Clostridium difficile colonisation and disease. Lancet (1990) 3.17

Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J Clin Microbiol (1983) 2.97

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol (1993) 2.94

Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol (1982) 2.86

The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis (1986) 2.61

Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1986) 2.43

Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea. J Clin Microbiol (1987) 2.34

Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29

Clostridium difficile: clinical considerations. Rev Infect Dis (1990) 2.28

DNA fingerprints of Streptococcus pyogenes are M type specific. J Infect Dis (1988) 2.27

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis (1989) 2.08

Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95

Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1988) 1.93

Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A. J Clin Microbiol (1992) 1.61

Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates. J Clin Microbiol (1990) 1.60

Polyacrylamide gel electrophoresis patterns produced by Clostridium difficile. Rev Infect Dis (1984) 1.56

Relationship between indole production and differentiation of Klebsiella species: indole-positive and -negative isolates of Klebsiella determined to be clonal. J Clin Microbiol (1993) 1.53

Restriction endonuclease analysis of nosocomial isolates of Clostridium difficile. J Clin Microbiol (1987) 1.52

Characterization of a nosocomial Clostridium difficile outbreak by using plasmid profile typing and clindamycin susceptibility testing. J Infect Dis (1988) 1.52

In vivo translation of a region within the rrnB 16S rRNA gene of Escherichia coli. J Bacteriol (1987) 1.33

Epidemiologic markers of Clostridium difficile. Rev Infect Dis (1990) 1.07

Development and application of a multiple typing system for Clostridium difficile. Appl Environ Microbiol (1991) 0.95

Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo. Antimicrob Agents Chemother (1992) 0.91

Articles by these authors

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06

Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11

Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis (1993) 7.60

Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet (1994) 6.47

Infections in patients with diabetes mellitus. N Engl J Med (1999) 5.39

Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77

How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (1997) 4.28

Medium-dependent variation in bactericidal activity of antibiotics against susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1978) 4.28

DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol (1991) 4.20

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA (1995) 4.18

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis (1984) 4.10

Clostridium difficile--associated diarrhea. Clin Infect Dis (1998) 4.06

Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med (1983) 3.97

Assessment and management of foot disease in patients with diabetes. N Engl J Med (1994) 3.83

MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques. Antimicrob Agents Chemother (1984) 3.59

Diphtheroid prosthetic valve endocarditis. A study of clinical features and infecting organisms. Am J Med (1980) 3.59

Survival of influenza viruses on environmental surfaces. J Infect Dis (1982) 3.51

Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis (1995) 3.49

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis (1992) 3.37

Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet (1998) 3.29

Prosthetic valve endocarditis. Analysis of 38 cases. Circulation (1973) 3.29

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis (1997) 3.29

Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med (1981) 3.25

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet (1983) 3.24

Nosocomial Clostridium difficile colonisation and disease. Lancet (1990) 3.17

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother (1999) 3.16

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med (1999) 3.08

Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol (1994) 3.06

Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med (1986) 3.06

Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol (2006) 3.05

Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Antimicrob Agents Chemother (1980) 3.02

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol (1993) 2.94

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis (2001) 2.94

Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev Infect Dis (1980) 2.91

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med (1999) 2.87

Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med (2001) 2.72

Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61

Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect Immun (1977) 2.59

Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med (1999) 2.56

Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56

Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis (2001) 2.53

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med (1994) 2.44

Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits. Antimicrob Agents Chemother (1976) 2.39

Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Arch Intern Med (1979) 2.34

Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation (2000) 2.32

Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics. J Infect Dis (1977) 2.32

Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32

Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol (2001) 2.31

Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29

Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect Immun (1991) 2.29

Physical characterization of ten R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections. Antimicrob Agents Chemother (1979) 2.21

Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol (1993) 2.20

Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania. Int J Tuberc Lung Dis (2011) 2.19

Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15

Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13

Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12

Epidemiologic and clinical utility of typing systems for differentiating among strains of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (1991) 2.09

Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA (1995) 2.09

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis (1989) 2.08

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis (2003) 2.06

An outbreak of rubella among hospital personnel. N Engl J Med (1980) 2.05

Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03

Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol (1997) 2.02

Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med (1992) 2.00

Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis (1998) 1.97

Clonal relationships among bloodstream isolates of Escherichia coli. Infect Immun (1995) 1.95

Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95

Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1988) 1.93

Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis (2001) 1.92

Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin Infect Dis (1993) 1.92

Incidence of infection in systemic lupus erythematosus. Arthritis Rheum (1974) 1.89

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med (2001) 1.86

Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis (1988) 1.86

Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis (1984) 1.85

Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med (1996) 1.84

Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis (1997) 1.82

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol (1997) 1.82

Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80

Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model. J Infect Dis (1982) 1.77

Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis (1979) 1.77

Enterococcal endocarditis: a comparison of prosthetic and native valve disease. Rev Infect Dis (1991) 1.77

Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J Clin Microbiol (1994) 1.73

Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun (1992) 1.67

Clinical features of microsporidiosis in patients with AIDS. Clin Infect Dis (1994) 1.65

Phyloproteomics: species identification of Enterobacteriaceae using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Mol Microbiol Biotechnol (2001) 1.65

Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med (1995) 1.64

Adequacy of fellowship training: results of a survey of recently graduated fellows. Clin Infect Dis (2001) 1.63